NCT01672736: A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma |
|
|
| Terminated | 1/2 | 19 | Canada, US | ASP7487, Velcade, Dexamethasone, ASP7487, Bortezomib, Dexamethasone | University Health Network, Toronto, Multiple Myeloma Research Consortium, Astellas Pharma Inc | Multiple Myeloma | 03/17 | 12/17 | | |
